TCT-133 Thirty-Day Readmissions After Medical vs. Endovascular Therapy for Atherosclerotic Renal Artery Stenosis: Insights from the National Readmissions Database

Multiple randomized trials have failed to demonstrate an incremental benefit of renal artery stenting (RAS) over medical therapy alone (MT) for atherosclerotic renal artery stenosis (ARAS). However, patients with ARAS and acute coronary syndromes (ACS), decompensated heart failure (CHF), and/or